Functions of Shp2 in cancer

J Zhang, F Zhang, R Niu - Journal of cellular and molecular …, 2015 - Wiley Online Library
Diagnostics and therapies have shown evident advances. Tumour surgery, chemotherapy
and radiotherapy are the main techniques in treat cancers. Targeted therapy and drug …

Therapeutic potential of targeting SHP2 in human developmental disorders and cancers

D Shen, W Chen, J Zhu, G Wu, R Shen, M **… - European Journal of …, 2020 - Elsevier
Abstract Src homology 2 (SH2)-containing protein tyrosine phosphatase 2 (SHP2), encoded
by PTPN11, regulates cell proliferation, differentiation, apoptosis and survival via releasing …

Structure, function, and pathogenesis of SHP2 in developmental disorders and tumorigenesis

WQ Huang, Q Lin, X Zhuang, LL Cai… - Current cancer drug …, 2014 - ingentaconnect.com
Src homology 2 (SH2)-containing protein tyrosine phosphatase 2 (SHP2), encoded by the
human PTPN11 gene, is a ubiquitously expressed protein tyrosine phosphatase (PTP) that …

Structure and function of Gab2 and its role in cancer

CB Ding, WN Yu, JH Feng… - Molecular medicine …, 2015 - spandidos-publications.com
The docking proteins of the Grb-associated binder (Gab) family transduce cellular signals
between receptors and intracellular downstream effectors, and provide a platform for protein …

FLT3-ITD Activates RSK1 to Enhance Proliferation and Survival of AML Cells by Activating mTORC1 and eIF4B Cooperatively with PIM or PI3K and by Inhibiting Bad …

D Watanabe, A Nogami, K Okada, H Akiyama… - Cancers, 2019 - mdpi.com
FLT3-ITD is the most frequent tyrosine kinase mutation in acute myeloid leukemia (AML)
associated with poor prognosis. We previously found that FLT3-ITD activates the …

Targeted phosphoproteomics of insulin signaling using data-independent acquisition mass spectrometry

BL Parker, G Yang, SJ Humphrey, R Chaudhuri… - Science …, 2015 - science.org
A major goal in signaling biology is the establishment of high-throughput quantitative
methods for measuring changes in protein phosphorylation of entire signal transduction …

RSK inhibitors as potential anticancer agents: discovery, optimization, and challenges

Y Sun, L Tang, C Wu, J Wang, C Wang - European Journal of Medicinal …, 2023 - Elsevier
Ribosomal S6 kinase (RSK) family is a group of serine/threonine kinases, including four
isoforms (RSK1/2/3/4). As a downstream effector of the Ras-mitogen-activated protein …

The landscape of protein tyrosine phosphatase (Shp2) and cancer

AU Rehman, MU Rahman, MT Khan… - Current …, 2018 - ingentaconnect.com
Role of Shp2: The dysregulation of cell signaling cascades associated with the cell
differentiation and growth, due to the deletion, insertion or point mutation in specific amino …

ERK1/2-RSK2 signaling in regulation of erα-mediated responses

DA Lannigan - Endocrinology, 2022 - academic.oup.com
Signaling via extracellular regulated kinase 1/2 (ERK1/2) and p90 ribosomal S6 kinase
(RSK), a downstream effector, mediates numerous processes. For example, ERK1/2-RSK …

RSK promotes prostate cancer progression in bone through ING3, CKAP2, and PTK6-mediated cell survival

G Yu, YC Lee, CJ Cheng, CF Wu, JH Song… - Molecular Cancer …, 2015 - AACR
Prostate cancer has a proclivity to metastasize to bone. The mechanism by which prostate
cancer cells are able to survive and progress in the bone microenvironment is not clear …